Voya Investment Management LLC Theravance Biopharma, Inc. Transaction History

Voya Investment Management LLC

  • $79.9 Billion
  • Q3 2024

A detailed history of Voya Investment Management LLC transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 13,903 shares of TBPH stock, worth $136,944. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,903
Previous 16,882 17.65%
Holding current value
$136,944
Previous $143,000 21.68%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$7.66 - $10.25 $22,819 - $30,534
-2,979 Reduced 17.65%
13,903 $112,000
Q2 2024

Dec 03, 2024
BUY
$8.29 - $9.92 $24,695 - $29,551
2,979 Added 21.43%
16,882 $143,000
Q2 2024

Aug 14, 2024
SELL
$8.29 - $9.92 $8,969 - $10,733
-1,082 Reduced 6.02%
16,882 $143,000
Q1 2024

Dec 06, 2024
BUY
$8.22 - $11.59 $33,381 - $47,066
4,061 Added 29.21%
17,964 $161,000
Q1 2024

May 15, 2024
SELL
$8.22 - $11.59 $49,911 - $70,374
-6,072 Reduced 25.26%
17,964 $161,000
Q4 2023

Feb 14, 2024
SELL
$8.58 - $11.4 $21,347 - $28,363
-2,488 Reduced 9.38%
24,036 $270,000
Q2 2023

Aug 14, 2023
BUY
$10.16 - $11.92 $5,842 - $6,854
575 Added 2.22%
26,524 $274,000
Q3 2022

Nov 14, 2022
BUY
$8.39 - $10.22 $11,813 - $14,389
1,408 Added 5.74%
25,949 $263,000
Q2 2022

Aug 15, 2022
SELL
$8.41 - $10.34 $137,881 - $169,524
-16,395 Reduced 40.05%
24,541 $222,000
Q1 2022

May 16, 2022
SELL
$8.33 - $12.96 $2,182 - $3,395
-262 Reduced 0.64%
40,936 $391,000
Q4 2021

Feb 14, 2022
BUY
$7.42 - $11.05 $148,169 - $220,657
19,969 Added 94.06%
41,198 $455,000
Q3 2021

Nov 15, 2021
BUY
$6.77 - $14.41 $1,543 - $3,285
228 Added 1.09%
21,229 $157,000
Q2 2021

Aug 16, 2021
SELL
$14.52 - $22.46 $8,915 - $13,790
-614 Reduced 2.84%
21,001 $305,000
Q1 2021

May 17, 2021
BUY
$16.57 - $21.08 $26,677 - $33,938
1,610 Added 8.05%
21,615 $441,000
Q4 2020

Feb 16, 2021
BUY
$14.89 - $20.16 $45,593 - $61,729
3,062 Added 18.07%
20,005 $355,000
Q2 2020

Aug 14, 2020
SELL
$20.64 - $30.69 $143,282 - $213,049
-6,942 Reduced 29.06%
16,943 $356,000
Q1 2020

May 15, 2020
BUY
$17.84 - $31.21 $47,329 - $82,800
2,653 Added 12.5%
23,885 $552,000
Q4 2019

Feb 14, 2020
BUY
$16.12 - $25.89 $38,720 - $62,187
2,402 Added 12.76%
21,232 $550,000
Q2 2019

Aug 14, 2019
BUY
$15.6 - $25.15 $13,977 - $22,534
896 Added 5.0%
18,830 $307,000
Q1 2019

May 15, 2019
SELL
$22.57 - $28.15 $13,158 - $16,411
-583 Reduced 3.15%
17,934 $407,000
Q4 2018

Feb 14, 2019
BUY
$22.52 - $35.07 $21,213 - $33,035
942 Added 5.36%
18,517 $474,000
Q2 2018

Aug 14, 2018
SELL
$22.06 - $25.52 $30,332 - $35,090
-1,375 Reduced 7.26%
17,575 $399,000
Q3 2017

Nov 14, 2017
BUY
$23.88 - $34.96 $452,526 - $662,492
18,950
18,950 $649,000

Others Institutions Holding TBPH

# of Institutions
122
Shares Held
47.3M
Call Options Held
200
Put Options Held
12.8K
View Full List

About Theravance Biopharma, Inc.

TBPH Quotes by TradingView
  • Ticker TBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,782,400
  • Market Cap $658M
  • Description
  • Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...
More about TBPH
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email